The complement system
The complement system is an enzymatic cascade composed of around thirty participants whose purpose is the production of the membrane attack complex (MAC). However, certain intermediate players exert their own function, such as C4d forming tissue deposits or C3a, which is a powerful pro-inflammatory molecule.
It is one of the pillars of the non-specific immune reaction, although one of the activation pathways uses antibodies, which could make it an actor on the border of innate and specific immunity.
The components of the complement cascade are most often produced by the liver, but also by immunity actors, such as macrophages. Complement components represent approximately 15% of the globulin fraction of plasma proteins, or 3 mg/mL!
Description of the complement cascade
There are three pathways of complement cascade activation: the classical pathway, the lectin pathway, and the alternate pathway.
Regardless of the activation pathway:
- The pivot of the complement cascade is represented by C3 convertase
C3 convertase constitutes an important amplification step in the inflammatory reaction because a single C3 convertase molecule can cleave hundreds of C3 molecules. There are two types of C3 convertase, which have exactly the same effect, namely the cleavage of C3 into:
- A small C3a fragment which is an anaphylatoxin.
- A larger C3b fragment, which will attach to the C3 convertase to form the C5 convertase on the one hand, and have an opsonin function on the other hand.
- The second crucial point in the cascade is C5 convertase
C5 convertase cleaves C5 into:
- A small C5a fragment, which is an anaphylatoxin.
- A larger C5b fragment which initiates the formation of the membrane attack complex.
- Formation of the membrane attack complex
The membrane attack complex is a molecular structure capable of embedding itself in the membranes of cells or pathogens to induce their lysis. It is the product of the successive assembly of fragments C5b, C6, C7, C8, and then multiple C9, which form the pore itself.
Main activation pathways
The classical pathway
The formation of immune complexes allows the binding of the C1 complex, which will successively cleave C4 and C2 to form the C3 convertase C4b2a.
Only IgM and IgG isotypes can be recognised by the C1 complex, and initiate the complement cascade. IgA, IgD and IgE isotypes do not activate complement.
The lectin pathway
The recognition of certain carbohydrate motifs often associated with pathogens by lectins allows the binding of MASP. The lectin/MASP complex then behaves exactly like the C1 complex, and will therefore successively cleave C4 and C2 to form the same C3 convertase as in the classic pathway, namely C4b2a.
The alternative pathway
The C3 fragment, when present in large quantities in serum, is capable of autohydrolysing and recruiting protein B. The association of hydrolyzed C3 and the Bb fragment constitutes the C3 convertase of the alternative pathway, C3bBb. It should be noted that the C5 convertase of the alternative pathway is different from that of the classical pathway and the lectin pathway, but exerts strictly the same activity.
Functions of the complement cascade
Function | Factors involved | Principle |
---|---|---|
C3b and C4b | C3b and C4b can attach to the surface of pathogens and cell membranes. They are then recognised by C3b and C4b receptors on the surface of phagocytic cells, which leads to the potentiation of their functions. | |
Enhanced inflammatory response | C3a, C4a, and C5a = ANAPHYLATOXINS | Anaphylatoxins enhance the inflammatory response via capillary vasodilation, increased vascular permeability, chemotaxis exerted on different leukocyte populations, and the production of free radicals. |
Creation of the membrane attack complex | C5b, C6, C7, C8, and multiple C9 | The membrane attack complex is responsible for cell lysis and lysis of pathogens thanks to osmotic phenomena |
Enhanced antigen presentation | MBL, C1q, C3b, C4b, and C5a |
|
Enhanced humoral response | C3d, C3b, and C4b | C3d se lie de façon covalente à l’antigène. L’antigène est reconnu par le BCR tandis que le CD21 reconnait le C3d. Le CD21 est donc un co-récepteur de l’antigène renforçant la stabilité du complexe BCR/CD19/CD21 |
Endothelial and platelet activation | ? | Microvascular thrombosis, itself inducing a pro-inflammatory state, inducing a vicious circle inflammation > thrombosis > necrosis > inflammation |
Enhanced cytotoxic response | Little known mechanisms but C3 deficiency reduces CD8 and CD4 responses |
C4d, immunohistochemical marker of complement activation
In the process of regulating the complement cascade, C4b is inactivated by cleavage. One of the products of this cleavage is C4d which has the property of attaching covalently (therefore relatively stable over time, from a few days to a few months) to the surface of endothelial cells in particular. C4d is therefore a marker of complement activation by the classical pathway.
C4d deposition is used in clinical practice as a marker of complement activation, notably through the Banff classification.
0 = no C4d marking
1 = marking 0 to 9% of capillaries
2 = marking 10 to 50% of capillaries
3 = marking more than 50% of capillaries
What should be remembered
The complement system describes an enzymatic cascade whose purpose is the synthesis of the membrane attack complex. The membrane attack complex is the product of the common pathway of the system, which can be entered through three different pathways: the classical pathway, the alternate pathway, and the lectin pathway. Interestingly, the classical pathway includes antibody-dependent activation.
The complement system is a major actor in innate immunity through the power of the membrane attack complex. However, many intermediate actors are also important actors in the immune response (C4d, C3a, etc.).